| |
Important related
resources available to the Bloomfield Centre
Jewish General Hospital - McGill University Memory Clinic
Dr.
Howard Chertkow and Dr. Howard Bergman are co-directors of this
multi-disciplinary clinic combining the expertise of nurses,
psychologists, and physicians from
Geriatric Medicine and Neurology. The clinic provides coordinated assessment
and diagnosis of patients, and training of residents and physicians in the area
of cognitive problems. It has proven to be a powerful clinical research base,
with a large cohort of memory-impaired patients who are often recruited into
research studies. Over 500 new elderly individuals with memory impairment are
assessed each year at the clinic. A large number of industry-supported and investigator
driven drug studies have been organized and run through the clinic, which routinely
leads the country in its ability to recruit memory-impaired or AD subjects into
studies of new therapies.
Centre for Neurotranslational Research (CNR)
The Centre for Neurotranslational Research (CNR) is directed
by Hyman M. Schipper, MD, PhD, FRCPC. The Primary Mission of
the Centre is to facilitate the implementation of new therapies
and diagnostic tools for the management of patients suffering from
Alzheimer disease, Parkinson disease, multiple sclerosis,
stroke, neuromuscular
diseases and cancer of the nervous system. A major focus of the
CNR is the development of novel and effective antioxidant medications
and nutriceuticals to slow or arrest neuronal loss and associated
clinical decline in Alzheimer disease and other degenerative
brain disorders. When fully operational, the CNR will encompass
five Neural
Therapy Programs (1-Neuroprotection, 2-Immunomodulation, 3-Gene
Therapy, 4-Antiproliferation, and 5-Neuropharmacology).
McGill Consortium for Brain Imaging Research (MCBIR)
The Bloomfield Centre is the "aging and neurodegeneration" axis of
MCBIR, a consortium directed by Dr. Alan Evans of the MNI. Recently, the group
was awarded a Canadian Foundation for Innovation grant worth 34 million dollars.
This will result in development at McGill of one of the world's best neuroimaging
facilities, and as part of this an imaging data analysis centre will be constructed
at the Bloomfield Centre. This will enable cutting edge imaging of dementia and
AD patients, as well as animal models, using PET, fMRI, and other imaging modalities.
Centre for Clinical Epidemiology and Community Studies
- Dr. Christina Wolfson
Dr. Wolfson, one of the country's
leading expert on population studies of dementia, is director
of the Centre for Epidemiology
and Biostatistics at JGH. Her group
studies many aspects of aging and degenerative disease, from diagnosis, to medication
use. She is also involved in research into multiple sclerosis and other neurological
conditions.
Quebec Consortium
for Alzheimer’s Disease and related
Neurodegenerative Disorders / Consortium Québecois pour
la Maladie d’Alzheimer et Maladies Neurodégénératives
connexes
In January 2001, researchers from across
Quebec met to create a “Quebec
Consortium for Alzheimer’s Disease and related Neurodegenerative Disorders.
The major goal of this consortium will be to bring together researchers focused
on Alzheimer’s Disease and related neurodegenerative disorders in order
to promote synergy, collaboration, meaningful interaction, and sharing of
resources. One goal will be to establish centralized resources for research
on AD and
other neurodegenerative diseases such as ALS. These facilities will be fully
accessible to all consortium members. The consortium will develop stronger
collaboration between researchers, as well as serving as an interface with
the Alzheimer’s Society, the public, and industry. Dr. Howard
Chertkow has assumed a coordination position to push this initiative ahead
as rapidly
as possible.
|
